Search

A wide variety of acetaminophen dosage forms have been administered to relieve mild to moderate pain and fever, so far. The purpose of this study was to compare the oral bioavailability in healthy volunteers, of three of these dosage forms. We included healthy volunteers in our study and divided replace with placed them into three groups: tablet, capsule and effervescent. Each dosage form contained 500 mg of acetaminophen as active material. Blood samples were taken at 0.5, 1, 2, 4 and 8-hour intervals after receiving the dose. Acetaminophen blood levels were measured using HPLC method. Data were fit in a "one-compartment PK model", using P-Pharm 1.5 software and analyzed under statistical tests. The maximum concentrations of acetaminophen in blood samples were measured at 1h after taking the drug (6.61±3.19 µg/ml, 11.29±3.94 µg/ml and 15.25±2.54 µg/ml in groups receiving capsule, tablet and effervescent, respectively). Pharmacokinetic (PK) data analysis & modeling from the three groups showed that the half-life of acetaminophen was 140.72 min in the tablet group, 140.29 min in capsule and 132.08 min in effervescent. The area under the blood levels curve were 47.04, 40.62 and 53.11 µgmin/ml, in tablet, capsule, and effervescent groups, respectively. Statistically significant differences in PK parameters were recorded as the study replace with we compared effervescent with tablets and capsule dosage forms (p < 0.05). According to the results, the effervescent form creates better PK parameters compared with tablet and capsule forms, therefore, it is suggested replace with we suggested that this form should be administer in cases of pain and fever to achieve quick drug efficacy. [ABSTRACT FROM AUTHOR]

In recent years, extensive evidence has been published about usage of laser in oral lesions. The aim of the present study was to review the effectiveness of laser radiation in the treatment of pediatric oral soft tissue problems. The relevant keywords were searched in EBSCO, Medline (via Ovid), PubMed, Scopus, and Web of Science (WOS) databases. Then, eligible case series and controlled clinical trial studies, which published up to the end of 2018, were extracted and scrutinized. In this study, the age range of ≤ 21 years or the average age of ≤ 21 years was considered as the pediatric group. After limiting the search results, removing duplicate titles and eligibility evaluation, 17 papers were enrolled to the study (seven controlled clinical trials and ten case series). Er:YAG (2940 nm), CO2 (10,600 nm), Er,Cr:YSGG (2780 nm), and diode (650, 660, and 975 nm) lasers indicated successful clinical results on mucocele excision, frenectomy, gingival incision and re-contouring, and treatment of vascular malformations. In addition, 660-nm diode laser radiation was an effective adjuvant treatment for halitosis and gingivitis induced by multi-bracket appliances. Reduction or absence of pain and bleeding, suitable homeostasis, reduction of operation time, less analgesic consumption, and antibacterial effect were among the advantages of the laser radiation in the studies. Laser as a main or adjuvant tool can have an effective role in surgical and non-surgical treatments of pediatric oral soft tissue problems. Conducting further randomized controlled trial studies on different soft tissue lesions can contribute to drawing better conclusions. [ABSTRACT FROM AUTHOR]

Background: Upper gastrointestinal bleeding (UGIB) is an important complication of low-dose aspirin. There are few and conflicting results about the etiology of UGIB in relation to low-dose aspirin. The aim of the present study was to evaluate the upper gastrointestinal endoscopy of patients taking low-dose aspirin who developed UGIB. Materials and Methods: The medical records of patients with UGIB who referred to Fatemieh Hospital, Semnan, Iran during 2001-2011 were studied and eligible patients were enrolled to the study. The endoscopic data were extracted and compared between the patients taking low-dose aspirin and who were not taking aspirin (control). Results: 419 cases were studied. 58 (13.8%) patients consumed low-dose aspirin and 204 (48.7%) patients did not consume aspirin. The average age of the patients who received low-dose aspirin and those in the control groups were 65.9 ± 5.9 and 50.4 ± 22.3 years, respectively (p = 0.000). 46.6% and 32.4% of the patients in low-dose aspirin and control groups were women, respectively, and the remaining patients were men (p > 0.05). The main endoscopic findings in low-dose aspirin and control groups were erosions of the stomach, duodenum, and esophagus (55.9% and 51.7%) and peptic ulcer (50% and 43.6%), respectively. The other findings such as neoplasia, Mallory Weiss, and hiatal hernia were uncommon (1.7% and 5.9%). The prevalence of endoscopic findings was not statistically significant between the two groups (p > 0.05). Conclusion: In this small study, although patients with UGIB and low-dose aspirin consumption had more peptic ulcers and erosions in comparison with the control group, the difference was not significant. [ABSTRACT FROM AUTHOR]